Kevin T. Conroy - 26 Jan 2022 Form 4 Insider Report for Adaptive Biotechnologies Corp (ADPT)

Role
Director
Signature
/s/ Kevin Conroy by Eric Billings, attorney-in-fact
Issuer symbol
ADPT
Transactions as of
26 Jan 2022
Transactions value $
$0
Form type
4
Date filed
28 Jan 2022, 18:00
Previous filing
19 Jan 2022
Next filing
16 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADPT Common Stock Award $0 +6.69K +444.75% $0.00 8.19K 26 Jan 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADPT Stock Option (Right to Buy) Award $0 +16.7K $0.00 16.7K 26 Jan 2022 Common Stock 16.7K $14.95 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest in equal monthly installments over one year, subject to continued service as a director through such vesting date.